Patents by Inventor Chetan Pandit

Chetan Pandit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic sulfonamide derivatives
    Patent number: 8466289
    Abstract: The present invention relates to compounds of Formula I where R1a, R1b, X, R2a, R2b, W, R3, R4, and R5 are as defined herein as well as pharmaceutically acceptable salts thereof. The compounds have been shown to act as MEK inhibitors which may be useful in the treatment of hyperproliferative diseases, like cancer and inflammation.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: June 18, 2013
    Assignee: Novartis AG
    Inventors: Mark G. Bock, Dinesh Chikkanna, Clive McCarthy, Henrik Moebitz, Chetan Pandit
  • DIAZA-SPIRO[5.5]UNDECANES
    Publication number: 20120264748
    Abstract: The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    Type: Application
    Filed: December 20, 2010
    Publication date: October 18, 2012
    Applicant: NOVARTIS AG
    Inventors: Sangamesh Badiger, Dirk Behnke, Claudia Betschart, Vinod Chaudhari, Simona Cotesta, Jürgen Hans-Hermann Hinrichs, Silvio Ofner, Chetan Pandit, Jürgen Wagner
  • DISUBSTITUTED HETEROARYL-FUSED PYRIDINES
    Publication number: 20120258973
    Abstract: The invention relates to compound of the formula (I?) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    Type: Application
    Filed: December 20, 2010
    Publication date: October 11, 2012
    Applicant: NOVARTIS AG
    Inventors: Sangamesh Babiger, Dirk Behnke, Claudia Betschart, Vinod Chaudhari, Murali Chebrolu, Simona Cotesta, Samuel Hintermann, Arndt Meyer, Chetan Pandit
  • HETEROCYCLIC SULFONAMIDE DERIVATIVES
    Publication number: 20120245209
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases (e.g., cancer and inflammation).
    Type: Application
    Filed: December 7, 2010
    Publication date: September 27, 2012
    Applicant: NOVARTIS AG
    Inventors: Dinesh Chikkanna, Mark Gary Bock, Clive McCarthy, Henrik Moebitz, Chetan Pandit, Ramulu Poddutorri
  • Di/tri-aza-spiro-C9-C11alkanes
    Publication number: 20120165331
    Abstract: The invention relates to compounds of the formula I A-D-C(R1)2—B??(I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    Type: Application
    Filed: December 19, 2011
    Publication date: June 28, 2012
    Inventors: Sangamesh BADIGER, Dirk BEHNKE, Claudia BETSCHART, Vinod CHAUDHARI, Simona COTESTA, Samuel HINTERMANN, Andreas LERCHNER, Fatma LIMAM, Silvio OFNER, Chetan PANDIT, Jürgen WAGNER
  • Diaza-spiro[5.5]undecanes
    Publication number: 20120101110
    Abstract: The invention relates to compound of the formula I in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    Type: Application
    Filed: October 18, 2011
    Publication date: April 26, 2012
    Inventors: Sangamesh BADIGER, Dirk BEHNKE, Claudia BETSCHART, Simona COTESTA, Samuel HINTERMANN, Silvio OFNER, Chetan PANDIT, Bernard Lucien ROY
  • Heterocyclic Sulfonamide Derivatives
    Publication number: 20110190334
    Abstract: The present invention relates to compounds of Formula I where R1a, R1b, X, R2a, R2b, W, R3, R4, and R5 are as defined herein as well as pharmaceutically acceptable salts thereof. The compounds have been shown to act as MEK inhibitors which may be useful in the treatment of hyperproliferative diseases, like cancer and inflammation.
    Type: Application
    Filed: November 3, 2010
    Publication date: August 4, 2011
    Applicant: NOVARTIS AG
    Inventors: Mark G. Bock, Dinesh Chikkanna, Clive McCarthy, Henrik Moebitz, Chetan Pandit
  • Antibiotics containing borinic acid complexes and methods of use
    Patent number: 7888356
    Abstract: The structure and preparation of antibiotics incorporating borinic acid complexes are disclosed, especially hydroxyquinoline, imidazole and picolinic acid derivatives, along with compositions of these antibiotics and methods of using the antibiotics and compositions as bactericidal and fungicidal agents as well as therapeutic agents for the treatment of diseases caused by bacteria and fungi.
    Type: Grant
    Filed: January 9, 2008
    Date of Patent: February 15, 2011
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Ving Lee, Stephen J. Benkovic, Stephen J. Baker, Kirk R. Maples, Tsutomu Akama, Yong-Kang Zhang, Rajesjwar Singh, Vittorio A. Sauro, Chetan Pandit, Zhuoyi Su, Zhixiang Yang
  • Heterocyclic Compounds as MEK Inhibitors
    Publication number: 20090275606
    Abstract: The present invention relates to compounds of formula I and pharmaceutically acceptable salts. These compounds can act as potential MEK inhibitors in the treatment of hyperproliferative diseases, like cancer and inflammation. The present invention also reveals methods of preparation thereof.
    Type: Application
    Filed: April 21, 2009
    Publication date: November 5, 2009
    Inventors: Dinesh Chikkanna, Clive McCarthy, Henrik Moebitz, Chetan Pandit, Ramesh Sistla, Hosahalli Subramanya
  • ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHODS OF USE
    Publication number: 20080293675
    Abstract: The structure and preparation of antibiotics incorporating borinic acid complexes are disclosed, especially hydroxyquinoline, imidazole and picolinic acid derivatives, along with compositions of these antibiotics and methods of using the antibiotics and compositions as bactericidal and fungicidal agents as well as therapeutic agents for the treatment of diseases caused by bacteria and fungi.
    Type: Application
    Filed: January 9, 2008
    Publication date: November 27, 2008
    Applicant: ANACOR PHARMACEUTCALS INC.
    Inventors: Ving Lee, Stephen Benkovic, Stephen Baker, Kirk Maples, Tsutomu Akama, Yong-Kang Zhang, Rajeshwar Singh, Vittorio Sauro, Chetan Pandit, Zhuoyi Su, Zhixiang Yang
  • Antibiotics containing borinic acid complexes and methods of use
    Patent number: 7390806
    Abstract: The structure and preparation of antibiotics incorporating borinic acid complexes are disclosed, especially hydroxyquinoline, imidazole and picolinic acid derivatives, along with compositions of these antibiotics and methods of using the antibiotics and compositions as bactericidal and fungicidal agents as well as therapeutic agents for the treatment of diseases caused by bacteria and fungi.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: June 24, 2008
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: Ving Lee, Stephen J. Benkovic, Stephen J. Baker, Kirk R. Maples, Tsutomu Akama, Yong-Kang Zhang, Rajeshwar Singh, Vittorio A. Sauro, Chetan Pandit, Zhuoyi Su, Zhixiang Yang
  • Antibiotics containing borinic acid complexes and methods of use
    Publication number: 20050070503
    Abstract: The structure and preparation of antibiotics incorporating borinic acid complexes are disclosed, especially hydroxyquinoline, imidazole and picolinic acid derivatives, along with compositions of these antibiotics and methods of using the antibiotics and compositions as bactericidal and fungicidal agents as well as therapeutic agents for the treatment of diseases caused by bacteria and fungi.
    Type: Application
    Filed: June 14, 2004
    Publication date: March 31, 2005
    Inventors: Ving Lee, Stephen Benkovic, Stephen Baker, Kirk Maples, Tsutomu Akama, Yong-Kang Zhang, Rajeshwar Singh, Vittorio Sauro, Chetan Pandit, Zhuoyi Su, Zhixiang Yang